Over the past six years, China’s minimally invasive cardiovascular surgery has achieved a leap from concept popularization to system restructuring at an astonishing pace: technological boundaries are expanding, regional gaps are narrowing, and the disciplinary structure is rebalancing. This is a quiet yet profound revolution, a transformation reshaping the fates of patients nationwide.